Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01772550 · ClinicalTrials.gov registry record · NA
Study of Effectiveness of Smaller Gauge Fenestrated Catheters for Use in IV Contrast Enhanced CT Scans
A NA study of Contrast Enhanced Computed Tomography, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- NA
- Development phase
- 238
- Enrollment target
- 1
- Study location
NCT01772550 is a NA study of Contrast Enhanced Computed Tomography that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 238 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01772550, a NA study of Contrast Enhanced Computed Tomography, has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 238 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare multidetector computed tomography (CT) image quality following peripheral venous high pressure injection of iodinated intravenous contrast media between a 20 gauge (GA) fenestrated, intravenous catheter (BD Nexiva™ Diffusics™) and an 18 GA non-fenestrated, intravenous catheter. In the contrast enhanced CT procedure (CECT), a machine (power injector) is used to rapidly deliver contrast agent to an individual's circulatory system. The contrast allows for greater differentiation of tissues in images of the area of interest, affording a better opportunity to visually assess the area and hence make a more accurate diagnosis. CECT often requires a high rate of contrast flow (≥ 5 mL/sec) through the IV catheter to provide sufficient contrast for an acceptable image. Typically an 18 GA IV catheter is required to achieve these high flow rates; however, often the patient does not have a vein that will accommodate this large size catheter. The BD Nexiva™ Diffusics™ IV catheter is designed to deliver a higher flow rate than a conventional catheter of the same gauge by incorporating fenestrations (small openings) near the tip of the catheter that allow fluid to exit the catheter in addition to that which normally exits through the main opening at the tip of the catheter.
Conditions Studied
Interventions
- DEVICE 20GA BD Nexiva Diffusics
- DEVICE 18GA Conventional Catheter
Study Locations (1)
Maryland
- Johns Hopkins Outpatient Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01772550
The ClinicalTrials.gov registry entry for NCT01772550 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Becton, Dickinson and Company, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Contrast Enhanced Computed Tomography appearing as the primary indexed condition, and to 2 interventions - of which 20GA BD Nexiva Diffusics is the first listed.
NCT01772550 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01772550 about?
NCT01772550 is a clinical study titled "Study of Effectiveness of Smaller Gauge Fenestrated Catheters for Use in IV Contrast Enhanced CT Scans". The purpose of this study is to compare multidetector computed tomography (CT) image quality following peripheral venous high pressure injection of iodinated intravenous contrast media between a 20 gauge (GA) fenestrated, intravenous catheter (BD Nexiva™ Diffusics™) and an 18 GA non-fenestrated, int...
What is the current status of trial NCT01772550?
This trial is currently completed. It is a NA study. The enrollment target is 238 participants. The study started on 2013-01. Estimated completion is 2013-02.
What conditions does trial NCT01772550 study?
This clinical trial studies the following conditions: Contrast Enhanced Computed Tomography.
What interventions are being tested in trial NCT01772550?
The interventions under investigation include: 20GA BD Nexiva Diffusics (DEVICE), 18GA Conventional Catheter (DEVICE).
Who is sponsoring clinical trial NCT01772550?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01772550 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.